ADMA vs COP · P/E 22, rev $426.5M vs P/E 19, rev $58.94B
ADMA Biologics Inc (ADMA) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported ADMA revenue for 2024-12-31 was $426.5M. Net income was $197.7M. Revenue was up 65.2% from 2023-12-31 to 2024-12-31. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the ADMA and COP stock pages for the full models.
Not investment advice.